Latest Insider Transactions at Rapt Therapeutics, Inc. (RAPT)
This section provides a real-time view of insider transactions for Rapt Therapeutics, Inc. (RAPT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RAPT Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RAPT Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2022
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-3.18%
|
$80,000
$40.0 P/Share
|
|
Jan 04
2022
|
William Ho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,778
+3.06%
|
$46,224
$8.16 P/Share
|
|
Jan 03
2022
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
820
-4.14%
|
$29,520
$36.73 P/Share
|
|
Dec 10
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,647
-11.79%
|
$79,410
$30.88 P/Share
|
|
Dec 10
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,647
+10.54%
|
$15,882
$6.3 P/Share
|
|
Dec 03
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-4.99%
|
$96,000
$32.26 P/Share
|
|
Nov 11
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,648
-11.79%
|
$92,680
$35.69 P/Share
|
|
Nov 11
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,648
+10.55%
|
$15,888
$6.3 P/Share
|
|
Oct 18
2021
|
Wendye Robbins |
BUY
Open market or private purchase
|
Direct |
500
+5.1%
|
$15,000
$30.7 P/Share
|
|
Oct 13
2021
|
Wendye Robbins |
BUY
Open market or private purchase
|
Direct |
400
+4.35%
|
$11,600
$29.69 P/Share
|
|
Oct 13
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-4.75%
|
$87,000
$29.69 P/Share
|
|
Oct 11
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,647
-11.79%
|
$79,410
$30.78 P/Share
|
|
Oct 11
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,647
+10.54%
|
$15,882
$6.18 P/Share
|
|
Sep 27
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
9,239
-100.0%
|
$314,126
$34.8 P/Share
|
|
Sep 27
2021
|
Column Group Ii, LP > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
9,239
+50.0%
|
$212,497
$23.26 P/Share
|
|
Sep 20
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-3.07%
|
$80,000
$40.0 P/Share
|
|
Sep 17
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-0.62%
|
$76,000
$38.92 P/Share
|
|
Sep 15
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
33,535
-86.39%
|
$1,240,795
$37.45 P/Share
|
|
Sep 14
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
147,676
-44.56%
|
$5,316,336
$36.63 P/Share
|
|
Sep 13
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,317
-7.98%
|
$501,095
$35.27 P/Share
|
|
Sep 10
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,738
-10.69%
|
$760,830
$35.19 P/Share
|
|
Sep 10
2021
|
Column Group Ii, LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
497,048
+46.13%
|
-
|
|
Sep 10
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
279,710
-100.0%
|
-
|
|
Sep 10
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
1,166,666
-45.42%
|
-
|
|
Sep 10
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,648
-11.79%
|
$92,680
$35.78 P/Share
|
|
Sep 10
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,648
+10.55%
|
$15,888
$6.18 P/Share
|
|
Sep 08
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-4.4%
|
$108,000
$36.04 P/Share
|
|
Sep 02
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,101
-100.0%
|
$1,298,535
$35.43 P/Share
|
|
Sep 01
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
31,749
-26.45%
|
$1,111,215
$35.23 P/Share
|
|
Aug 24
2021
|
Wendye Robbins |
BUY
Open market or private purchase
|
Indirect |
525
+10.72%
|
$15,750
$30.91 P/Share
|
|
Aug 24
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,867
-27.89%
|
$708,877
$31.31 P/Share
|
|
Aug 23
2021
|
Wendye Robbins |
BUY
Open market or private purchase
|
Indirect |
1,475
+28.31%
|
$45,725
$31.42 P/Share
|
|
Aug 23
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
68,340
-18.76%
|
$2,118,540
$31.57 P/Share
|
|
Aug 20
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,539
-3.04%
|
$136,170
$30.08 P/Share
|
|
Aug 20
2021
|
Wendye Robbins |
BUY
Open market or private purchase
|
Direct |
600
+3.43%
|
$17,400
$29.65 P/Share
|
|
Aug 18
2021
|
Column Group Ii, LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
373,090
+50.0%
|
-
|
|
Aug 18
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
208,403
-100.0%
|
-
|
|
Aug 18
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
1,317,005
-33.89%
|
-
|
|
Aug 16
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-1.45%
|
$32,000
$32.07 P/Share
|
|
Aug 11
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,647
-11.79%
|
$82,057
$31.19 P/Share
|
|
Aug 11
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,647
+10.54%
|
$15,882
$6.18 P/Share
|
|
Aug 06
2021
|
William Ho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,690
+5.07%
|
$44,280
$12.0 P/Share
|
|
Aug 04
2021
|
William Ho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
694
+0.53%
|
$4,164
$6.24 P/Share
|
|
Aug 02
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-1.52%
|
$30,000
$30.52 P/Share
|
|
Jul 23
2021
|
William Ho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,193
+6.01%
|
$49,158
$6.24 P/Share
|
|
Jul 15
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-1.71%
|
$30,000
$30.23 P/Share
|
|
Jul 12
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,648
-11.79%
|
$87,384
$33.53 P/Share
|
|
Jul 12
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,648
+10.55%
|
$15,888
$6.18 P/Share
|
|
Jul 07
2021
|
Wendye Robbins |
BUY
Open market or private purchase
|
Direct |
1,000
+6.19%
|
$30,000
$30.18 P/Share
|
|
Jul 01
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-1.68%
|
$31,000
$31.75 P/Share
|